Provided by Tiger Trade Technology Pte. Ltd.

COLLPLANT BIOTECHNOLOGIES LTD

0.6158
-0.0042-0.68%
Post-market: 0.61580.00000.00%18:14 EST
Volume:96.12K
Turnover:58.69K
Market Cap:8.87M
PE:-0.60
High:0.6533
Open:0.6199
Low:0.5900
Close:0.6200
52wk High:4.98
52wk Low:0.5500
Shares:14.40M
Float Shares:8.91M
Volume Ratio:0.83
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0244
EPS(LYR):-1.4500
ROE:-92.74%
ROA:-42.11%
PB:0.95
PE(LYR):-0.42

Loading ...

CollPlant Unveils Photocurable Filler Targeting Facial Volume Loss After GLP-1 Weight-Loss Therapy

Reuters
·
Feb 17

Collplant Biotechnologies Cut to Hold From Buy by D. Boral Capital

Dow Jones
·
Feb 06

CollPlant Biotechnologies Announces Issuance of Warrants and Ordinary Shares in $2 Million Offering

Reuters
·
Feb 05

CollPlant Biotechnologies Ltd. Held Shareholder Meeting

Reuters
·
Dec 31, 2025

Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 28, 2025

CollPlant Biotechnologies Ltd. Announces Date for Annual and Extraordinary General Meeting of Shareholders

Reuters
·
Nov 27, 2025

Collplant Biotechnologies Reports 2025 Third Quarter Financial Results

Reuters
·
Nov 26, 2025

CollPlant Biotechnologies Q3 Adj. EPS $(0.25) Misses $0.15 Estimate, Sales $77.000K Miss $4.845M Estimate

Benzinga
·
Nov 26, 2025

CollPlant Biotechnologies' Q3 revenue rises on rhCollagen sales, cuts workforce

Reuters
·
Nov 26, 2025

CollPlant reports Q3 non-GAAP EPS (25c) vs. (33c) last year

TIPRANKS
·
Nov 26, 2025

Collplant Biotechnologies 9M 2025 net loss narrows 35% to USD 8.3 million

Reuters
·
Nov 26, 2025

Press Release: COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Dow Jones
·
Nov 26, 2025

Collplant Biotechnologies Ltd. to Release Third Quarter 2025 Financial Results

Reuters
·
Nov 18, 2025

Collplant Biotechnologies Ltd expected to post earnings of 16 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025

CollPlant expands rhCollagen capabilities in U.S., Canada

TIPRANKS
·
Oct 27, 2025

Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Oct 20, 2025

Mayo Clinic Researchers Develop First Fully Humanized 3D Bioprinted Skin Model Using CollPlant's Plant-Derived rhCollagen

Reuters
·
Oct 16, 2025

CollPlant Biotechnologies Announces Positive Preclinical Results for Novel Photocurable Regenerative Dermal Filler, Paving Way for Clinical Trials

Reuters
·
Sep 30, 2025

Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 16, 2025

CollPlant Biotechnologies Expands Vergenix™ STR Distribution in Europe with New Polish Agreement

Reuters
·
Sep 15, 2025